Skip to main content
. 2021 Sep 30;12(6):1995–2006. doi: 10.1002/jcsm.12803

Table 4.

Results of multivariate Cox proportional hazards model in the derivation cohort

Variables Hazard ratio 95% Confidence interval P
Frailty category I 1 (reference)
Frailty category II 1.51 [0.84–2.72] 0.169
Frailty category III 2.37 [1.32–4.23] 0.004
Frailty category IV 2.66 [1.45–4.89] 0.002
Age, per 1 SD 1.04 [0.83–1.31] 0.730
Women 0.84 [0.61–1.14] 0.266
Past HF hospitalization 2.51 [1.83–3.43] <0.001
SBP at discharge, per 1 SD 1.08 [0.91–1.27] 0.376
HR at discharge, per 1 SD 1.08 [0.94–1.25] 0.282
Diabetes 1.24 [0.91–1.68] 0.167
Past cardiac surgery 0.97 [0.66–1.43] 0.896
Cancer 1.21 [0.76–1.91] 0.419
COPD 1.17 [0.68–2.00] 0.567
Orthopaedic disease 0.84 [0.45–1.57] 0.585
Stroke 0.44 [0.13–1.42] 0.171
High BNP level 1.74 [1.19–2.54] 0.004
eGFR, per 1 SD 0.80 [0.67–0.95] 0.013
Sodium, per 1 SD 0.91 [0.79–1.04] 0.186
Anaemia 1.19 [0.84–1.68] 0.334
Albumin, per 1 SD 0.89 [0.77–1.04] 0.140
LVEF < 40% 1.05 [0.75–1.48] 0.775
Beta blocker 0.98 [0.70–1.37] 0.907
ACEi/ARB 0.82 [0.60–1.10] 0.181
MRA 1.15 [0.85–1.57] 0.367
Diuretic 1.42 [0.89–2.26] 0.138
Oral inotropic agent 1.50 [1.03–2.19] 0.036
MMSE, per 1 SD 0.91 [0.84–0.99] 0.049
Depression 1.30 [0.97–1.76] 0.081
BMI, per 1 SD 0.85 [0.70–1.13] 0.096

ACEi, angiotensin‐converting enzyme; ARB, angiotensin II receptor blocker; BMI, body mass index; BNP, brain natriuretic peptide; COPD, chronic obstructive pulmonary disease; eGFR, estimated glomerular filtration rate; HF, heart failure; HR, heart rate; LVEF, left ventricular ejection fraction; MMSE, Mini‐Mental State Examination; MRA, mineral corticoid antagonist; SBP, systolic blood pressure.

Anaemia is defined as haemoglobin < 13 g/dL for men and <12 g/dL for women. High BNP level was defined as BNP ≥ 200 pg/mL or N‐terminal pro BNP ≥ 900 pg/mL. Depression is defined as 5‐item Geriatric Depression Scale ≥ 2 points.